Teva taps new CFO, hikes legal set-aside to more than $1B as opioid deal falters | Fierce Pharma
Teva Pharmaceutical Industries Limited 2018 Q2 - Results - Earnings Call Slides (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical earnings per share 2006-2021 | Statista
Teva Q2 Earnings: 5 Reasons Why Shares Rose By 30% (NYSE:TEVA) | Seeking Alpha
TEVA Gears Up to Report Q3 Earnings: What's in the Cards?
Teva Pharmaceutical beats Q4 earnings, sales estimates - Drug Delivery Business
Teva Pharmaceutical Industries Ltd. Meets Earnings Targets Despite a Mild European Winter | The Motley Fool
Teva reports jump in first-quarter earnings, raises guidance | The Times of Israel
Teva soars after earnings beat, increased guidance - TheStreet
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Teva earnings Q2 2018 | AlphaStreet
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror – PharmaLive
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Teva Pharmaceuticals on Twitter: "Our live Q2 2022 earnings call is starting soon! Join President & CEO Kåre Schultz to discuss Teva's business performance and plans ahead. Join here: https://t.co/VR9FyBqEz2 #QuarterlyResults #Earnings $
TEVA Stock | Teva Pharmaceuticals Q2 2020 Earnings Call - YouTube
TEVA Stock | Teva Pharmaceutical Industries Ltd Q3 2021 Earnings Call - YouTube
Teva Pharmaceutical revenue 2006-2021 | Statista
Teva Pharmaceutical Is in Recovery - WSJ
Teva Shares Spike After Q1 Earnings Beat, Full Year Forecast Boost - TheStreet
Teva tumbles as sales and earnings underwhelm
Teva ADR Earnings, Revenue Miss in Q3 By Investing.com
Teva Pharmaceutical: Earnings Trends and Recent Developments
Teva Pharmaceuticals Q4 2016 Earnings
Teva earnings: Facing down cheaper generic prices, generic competition of its own and a lot of debt - MarketWatch
